SenesTech, Inc. Stock News

Record Revenue and Margin Performance PHOENIX , Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercial and consumer available EPA-registered Rat Birth Control® products today announced financial results for the third quarter of 2024. Recent Highlights Re...

Significantly Expanding Market Reach PHOENIX , Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), a leader in fertility control solutions for managing animal pest populations, is excited to announce a significant expansion in the distribution of its groundbreaking rodent birth control product. Evolve™ Rat and Evolve™ Mouse are now available on Walmart Ma...

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX , Nov. 5, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2024, ended September 30, 2024, after the market close on Tuesday, November 12, 2024. The Company has scheduled a conference call that same day, Tuesday, November 12, 2024, at ...

PHOENIX , Oct. 31, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), the leader in birth control to manage rodent pest populations, today announces the successful registration of Evolve™ in Hong Kong. A Sustainable and Humane Approach to Rodent Control Hong Kong welcomes Evolve™, an innovative, non-lethal rodent birth control solution designed to target rat infestations at their root.

PHOENIX , Oct. 8, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), the leader in birth control to manage rodent pest populations, today announces that the New York City Council has approved a bill to implement a rat contraception pilot program. From the bill, the term "rat contraceptive" means an agent for the reduction of reproductive capacity in rats that is approved for such use by the U...

PHOENIX , Sept. 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced today it will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2024 Investor Conference, taking place virtually on Tuesday, October 1...

PHOENIX , Aug. 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced today the closing of an exercise of certain existing warrants to purchase 505,502 shares of the Company's common stock at a reduced exercise price of $4.60 per share. ...

SenesTech, Inc. (NASDAQ:SNES ) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Robert Blum – Lytham Partners Joel Fruendt – Chief Executive Officer Tom Chesterman – Chief Financial Officer Conference Call Participants Operator Good afternoon, and welcome to the SenesTech Reports Second Quarter Fiscal Year 2024 Results. [Operator Instructions] Please note this eve...